⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Marinomed Biotech AG and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Marinomed Biotech AG
↗Korneuburg, Austria
Marinomed Biotech AG is an Austrian biopharmaceutical company founded in 2006 as a spin-off from the University of Veterinary Medicine Vienna. The company specializes in developing innovative, patent-protected therapies for respiratory and ophthalmological diseases, leveraging its two proprietary technology platforms: Carragelose® (anti-viral) and Marinosolv® (solubilization of poorly soluble compounds).
Marinomed operates a lean business model, focusing on R&D and clinical validation while outsourcing manufacturing to partners and outlicensing late-stage assets for global commercialization. In 2026, the company expanded its business model to include compounding services, providing customized solutions for pharmacies using its Marinosolv technology.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Respiratory and Ophthalmological Therapeutics
SIZE & FINANCIALS
Employees:51-200
Founded:2006
Ownership:public
Status:operating
STOCK
Exchange:Vienna Stock Exchange
Ticker:MARI
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3 (Budesolv)
Modalities:Small molecule, Medical Devices
Active Trials:0
Trial Phases:Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Luoxin Pharmaceutical (Licensing), Various international OTC distribution partners
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Andreas Grassauer - CEO
Eva Prieschl-Grassauer - CSO
Scientific Founders:Andreas Grassauer, Eva Prieschl-Grassauer
LINKS
Website:marinomed.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Marinomed Biotech AG. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.